Ticker brief
SLS SELLAS LIFE SCIENCES GROUP I
Consumer, Non-cyclical · Pharmaceuticals
last close
$11.54
1 day
+1.7%
14 days
-0.9%
mkt cap
$2.9B
signals 14d
15
authors 14d
10
crowd 14d
-1.3σ
Options inteloptions-surface reads · latest available day per source
| metric | reading | context |
|---|---|---|
| IV — ATM 30d | 156% mid · 68 pctile own 1y | IV/HV 1.93× |
| Skew — 25Δ RR 30d | -0.016 33 pctile own 1y | balanced vs own range |
| Net dealer OI (NDOI) | +24.88 elevated | 5-session Δ -1.05 (as of 2026-07-16) |
| OI alarm | quiet | last alarm 2026-07-02 (z=2.4) |
| Next earnings | 2026-11-11 (proj) | in 16d |
| CSP screen | rank #109 · $9.5 strike · 0.53% prem | on the CSP screen (2026-10-23) |
Sentiment — last 14 days
daily mean sentiment, 2026-10-05 → 2026-10-16 · now -0.55 (−1 bearish … +1 bullish)
Who spoke10
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @TheNewMoney_app | C | · | 4 | -0.40 |
| @YYDSxjm | B | -0.25 | 2 | +0.82 |
| @Tickeron | C | +1.53 | 2 | -0.55 |
| @REXShares | C | -0.84 | 1 | +0.20 |
| @ClassicRoy | C | -1.10 | 1 | +0.00 |
| @ajoenamedjoe | C | -1.37 | 1 | +0.30 |
| @PK_Fund | C | -0.52 | 1 | +0.75 |
| @tsungrow | C | -0.47 | 1 | +0.00 |
| @InvestmentGuru_ | C | -2.08 | 1 | +0.35 |
| @Greatstockpix | C | -1.40 | 1 | +0.00 |
Recent signals15of 15 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-10-16 | @Tickeron | -0.55 | SLS fell 10.93% amid a broad selloff in high-beta biotech names. | +15.6% | tweet ↗ |
| 2026-10-16 | @Tickeron | -0.55 | Traders are de-risking ahead of a binary Phase 3 trial readout. | +15.6% | tweet ↗ |
| 2026-10-13 | @Greatstockpix | +0.00 | Publishes an October 14 day-trading watchlist without standalone entries or directional levels. | -7.0% | tweet ↗ |
| 2026-10-11 | @InvestmentGuru_ | +0.35 | Discloses that some names on the biotech watchlist are long-term holdings. | -0.9% | tweet ↗ |
| 2026-10-10 | @tsungrow | +0.00 | Highlights a large put holder facing forced settlement and warns of extreme movement in either direction. | -0.9% | tweet ↗ |
| 2026-10-08 | @YYDSxjm | +0.95 | Argues REGAL survival timing supports GPS efficacy and dismisses the bear case. | +2.5% | tweet ↗ |
| 2026-10-07 | @PK_Fund | +0.75 | Presents a broad bullish clinical, strategic and ownership thesis for SLS. | +2.0% | tweet ↗ |
| 2026-10-07 | @YYDSxjm | +0.70 | Expresses strong confidence in SLS trial data while urging better investor communication. | +2.0% | tweet ↗ |
| 2026-10-06 | @TheNewMoney_app | -0.40 | Reports bearish put flow with explicit transaction details. | +1.8% | tweet ↗ |
| 2026-10-06 | @TheNewMoney_app | -0.40 | Reports bearish put flow with explicit transaction details. | +1.8% | tweet ↗ |
| 2026-10-06 | @TheNewMoney_app | -0.40 | Reports bearish put flow with explicit transaction details. | +1.8% | tweet ↗ |
| 2026-10-06 | @TheNewMoney_app | -0.40 | Reports bearish put flow with explicit transaction details. | +1.8% | tweet ↗ |
| 2026-10-05 | @ajoenamedjoe | +0.30 | Notes retrospectively that SLS rallied strongly after an earlier tweet. | -0.8% | tweet ↗ |
| 2026-10-05 | @ClassicRoy | +0.00 | Lists highly shorted stocks using a named third-party news source | -0.8% | tweet ↗ |
| 2026-10-05 | @REXShares | +0.20 | Official ULTI portfolio update lists weekly additions and removals. | -0.8% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.